TSC22D3 and colitis: As shown in Figure 7, the intra-peritoneal delivery of TAT–GILZ protein protected against DNBS-induced colitis in mice, as evidenced by diminished body weight loss in WT and gilz cKO mice treated with TAT–GILZ compared with non-treated controls (Figure 7A).